UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
FDA okays first drug for Batten disease
Biomarin Pharmaceutical won the go-ahead from the U.S. Food and Drug Admini...
by Constance Williams
|
2017-04-28 15:49
라인
Court orders surgeon of dead musician to pay ₩1.6 billion
A local court has ordered the surgeon of the late singer Shin Hae-chul신해철 t...
by Choi Gwang-seok
|
2017-04-28 15:01
라인
JW Pharmaceutical worst of 10 major drugmakers for women to work in
In every election, presidential candidates have promised to shatter glass c...
by Nam Doo-hyun
|
2017-04-28 12:07
라인
FDA approves 1st treatment for liver cancer in decade
The U.S. Food and Drug Administration Thursday expanded the approved use of...
by Constance Williams
|
2017-04-28 11:25
라인
WHO official identifies medical barriers in low-income countries
The top 10 diseases have shifted from communicable to non-communicable sick...
by Constance Williams
|
2017-04-28 10:20
라인
Novartis Korea slammed with $48.6-million penalty
The Ministry of Health and Welfare has decided to impose the fine of 55.1 b...
by Marian Chu
|
2017-04-27 18:16
라인
Medical industry earned $761 million from 364,000 foreign patients last year
Korea’s medical industry attracted about 364,000 foreign patients and took ...
by Marian Chu
|
2017-04-27 17:27
라인
Boryung’s 1Q sales hit ₩99.8 billion
Boryung Pharmaceuticals보령제약 recorded sales of 99.8 billion won ($88.3 milli...
by Lee Hye-seon
|
2017-04-27 14:59
라인
How Daewoong released Korea’s 1st generic drug in US?
All eyes of Korean drugmakers are on Daewoong Pharmaceutical, as it has ach...
by Lee Hye-seon
|
2017-04-27 13:28
라인
Konkuk professor to participate in first full-body transplant
An Italian doctor and his team are about to perform one of the most talked-...
by Constance Williams
|
2017-04-27 10:33
라인
Expectations rise about new bio drug going global
AFSTYLA, a hemophilia therapy developed by SK Chemicals SK케미칼이 jointly with...
by Lee Hye-seon
|
2017-04-26 18:06
라인
Argentina set to simplify registering process of Korean medicines
Korean pharmaceutical companies will benefit from shorter and simpler proce...
by Marian Chu
|
2017-04-26 17:39
라인
Customized subfertility therapy to debut in Korea
REKOVELLE (compound: follitropin delta), the personalized subfertility trea...
by Lee Hye-seon
|
2017-04-26 16:22
라인
Artificial blood vessel provider to withdraw from Korea
Artificial blood vessels, which are indispensable for the surgery of childr...
by Marian Chu
|
2017-04-26 15:45
라인
Study finds 2 in 10 students hard of hearing
Inadequate hearing tests done by schools have been unable to find many teen...
by Marian Chu
|
2017-04-26 11:15
라인
FDA warns 14 firms against selling false cancer-curing products
The U.S. Food and Drug Administration (FDA) posted warning letters on Tuesd...
by Constance Williams
|
2017-04-26 10:49
라인
SillaJen to receive $4 million milestone thanks to ‘Pexa-Vec’
SillaJen신라젠, a Korean developer of bio drug, said Monday the first European...
by Constance Williams
|
2017-04-26 10:10
라인
Prohibition from solicitation of patients for profit making purpose
In Korea, most medical services are covered by the National Health Insuranc...
by Kim Sun-Wook and Kim Young-jun
|
2017-04-25 10:25
라인
Samsung Bioepis wins first FDA approval for biosimilar drug
The U.S. Food and Drug Administration Friday approved Samsung Bioepis’ rheu...
by Marian Chu
|
2017-04-24 18:18
라인
Will challenges by 30-something heirs succeed?: Kukje, Samil
Nam communicates actively in SNS, adding young sense to old traditionCEO Na...
by Lee Hye-seon
|
2017-04-24 13:05
-
이전
321
322
323
324
325
326
327
328
329
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top